Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products
Prodrugs are bioreversible, inactive drug derivatives, which have the ability to convert into a parent drug in the body. In the past, prodrugs were used as a last option; however, nowadays, prodrugs are considered already in the early stages of drug development. Optimal prodrug needs to have effecti...
Main Authors: | Milica Markovic, Shimon Ben-Shabat, Arik Dahan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/11/1031 |
Similar Items
-
Modern Prodrug Design for Targeted Oral Drug Delivery
by: Arik Dahan, et al.
Published: (2014-10-01) -
Molecular Modeling-Guided Design of Phospholipid-Based Prodrugs
by: Milica Markovic, et al.
Published: (2019-05-01) -
Prospects and Challenges of Phospholipid-Based Prodrugs
by: Milica Markovic, et al.
Published: (2018-11-01) -
Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico Simulations
by: Milica Markovic, et al.
Published: (2019-04-01) -
Regional Intestinal Drug Absorption: Biopharmaceutics and Drug Formulation
by: Arik Dahan, et al.
Published: (2021-02-01)